Just curious

Has any one noticed any difference between ventolin and salamol I find the salamol works for me quicker

[-Butterfly-]

I found salamol not as effective for me

[Hidden in reply to -Butterfly-]

Did u it's weird because it's meant to be the same hope your enjoying your day

[-Butterfly- in reply to Hidden]

Yeah I know lol. I think it's because the salamol I tried was an easibreathe inhaler, but ventolin in an mdi. I know it tasted different!

[PMRPete]

Ventolin vs Salbutamol: what’s the difference anyway?

echo.co.uk/blog/ventolin-vs...

[starveycat in reply to PMRPete]

Thanks PMRPete very interesting article 😀

[Hidden]

It's the same med just a different name 😊

[PMRPete]

"Salamol Inhalers - New Zealand Brand Switching Complaints Investigation"

Although this was some time ago, 2005, the problems surrounding the switch from Ventolin to Salamol in New Zealand was quite interesting; details here:-

medsafe.govt.nz/hot/PapersR...

Summary / Conclusions

Salamol inhalers are sensitive to cleaning and require cleaning in the manner described in the Patient information leaflet.

The launch of Salamol CFC-free inhalers onto the New Zealand market generated a significant number of patient complaints.

The complaints centred on decreased therapeutic effect generally associated with the blocking of the inhaler device, and unpleasant taste / mouth-feel.

The blocking of the inhaler appeared due to inadequate cleaning of the device. This was confirmed by testing of new and returned inhalers by ESR and TGAL, supported by data available from the manufacturer, IVAX.

All the new inhalers tested were found to meet their release specifications and international pharmacopoeial requirements for CFC-free inhalers.

During initial testing of new inhalers, one inhaler from a batch of new Salamol inhalers gave a high result for a modified pharmacopoeial dose uniformity test. The deviant result was not duplicated and taking other investigational findings into account, was discounted as a spurious result, the real issue being the importance of inhaler cleaning.

There appeared to be a lack of patient awareness regarding the cleaning requirements of Salamol inhalers, although, both Salamol and Ventolin inhalers carry statements to clean weekly.

Although brand switching information and cleaning information was available on the launch of Salamol in New Zealand, the amount and level of distribution of information appears to have been insufficient at launch in order to adequately inform patients and health professionals about the importance of cleaning.

The amount and distribution of patient information, particularly on cleaning of the device, has been improved.

In conclusion, following investigation and testing Medsafe was satisified that Salamol met the international requirements and guidelines for quality, safety and efficacy required for a medicine registered and distributed in New Zealand.